1. Drug-eluting and bare metal stents

Randomised trial of durable polymer zotarolimus-eluting versus biodegradable polymer sirolimus-eluting stents

BIONYX
Objective
to compare ZES with durable polymer versus SES with biodegradable polymer
Study
randomised, multicentre, non-inferiority trial
Population
all-comer population at 7 centres in Belgium, Netherlands, Israel
Endpoints
target vessel failure at 12 months
Conclusion
ZES was non-inferior to SES for clinical outcomes at 1 year
Von Birgelen et al. Lancet. 2018;392:1235-45
follow us
Copyright © 2025 Europa Group – All rights reserved.
The content of this site is intended for health care professionals.